Citation: Hk. Muller-hermelink et T. Rudiger, Malignant lymphomas and lymphoproliferative disorders following organ transplantation and immunomodulatory therapy, CONTR ONCOL, 55, 2000, pp. 117-138
Citation: A. Staratschek-jox et J. Bullerdiek, Chromosomal aberrations and molecular changes in therapy-related leukemias, CONTR ONCOL, 55, 2000, pp. 139-146
Citation: Jr. Soedirman, Secondary primary cancers after cancer and immunosuppressive chemotherapy and radiotherapy, CONTR ONCOL, 55, 2000, pp. 165-202
Citation: G. Benninger-doring et H. Wolf, Immunological aspects of the pathogenesis of tumors associated with Epstein-Barr virus: Vaccines for prevention and therapy, CONTR ONCOL, 55, 2000, pp. 275-285
Authors:
Leitch, HA
Cantarovich, M
Mangel, JE
Laneuville, P
Citation: Ha. Leitch et al., Posttransplant lymphoproliferative disorder - New approaches to monitoringand management, CONTR ONCOL, 55, 2000, pp. 305-346